← 返回

SPION 功能化 CAR-T 细胞:克服实体瘤治疗中的关键屏障

英文原题:SPION-functionalized CAR-T cells: Overcoming key barriers in solid tumor therapy.

查看英文原题

SPION-functionalized CAR-T cells: Overcoming key barriers in solid tumor therapy.

PubMed 2025/10/07(内容时间) Biochem Biophys Res Commun Q3 · IF 2.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

嵌合抗原受体(CAR)T细胞疗法治疗血液系统恶性肿瘤已取得显著成功,但其对实体瘤的疗效仍有限。主要障碍包括抗原表达异质性、肿瘤浸润不足以及强烈的免疫抑制性肿瘤微环境。此外,全身给予强效CAR-T 细胞常会引发细胞因子释放综合征(CRS)和神经毒性等严重毒性。超顺磁性氧化铁纳米颗粒(SPION)已成为应对这些挑战的多功能工具。其可利用磁场引导CAR-T 细胞在肿瘤部位聚集,有望克服浸润障碍并减少全身暴露;同时,其磁性也可用于通过磁共振成像(MRI)进行无创追踪。本综述总结了SPION功能化CAR-T 细胞的近期进展,重点介绍其通过改善靶向、降低全身毒性和实现实时成像来增强实体瘤治疗的潜力。

展开英文摘要原文

Chimeric antigen receptor (CAR)-T cell therapy has achieved remarkable success in the treatment of hematological malignancies, but its efficacy in solid tumors remains limited. Major barriers include heterogenous antigen expression, poor tumor infiltration, and a strongly immunosuppressive tumor microenvironment.

In addition, systemic administration of potent CAR-T cells frequently causes severe toxicities such as cytokine release syndrome (CRS) and neurotoxicity. Superparamagnetic iron oxide nanoparticles (SPIONs) have emerged as multifunctional tools to address these challenges. They enable magnetic field-guided accumulation of CAR-T cells at tumor sites, potentially overcoming infiltration barriers and reducing systemic exposure.

Simultaneously, their magnetic properties allow non-invasive tracking by magnetic resonance imaging (MRI). This review summarizes recent advances in SPION-functionalized CAR-T cells, highlighting their potential to enhance solid tumor therapy by improving targeting, reducing systemic toxicity, and enabling real-time imaging.

论文信息

作者
Carnell LR、Alexiou C、Janko C
第一作者单位
Department of Otorhinolaryngology, Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, Universitätsklinikum Erlangen, Erlangen, Germany.Germany
通讯作者单位
Department of Otorhinolaryngology, Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Else Kröner-Fresenius-Stiftung Professorship, Universitätsklinikum Erlangen, Erlangen, Germany. Electronic address: christina.janko@uk-erlangen.de.Germany
文献类型
综述 · 非美国政府资助研究
期刊
Biochemical and biophysical research communications2025 Nov 8
原文标识
PubMed 41106028 · DOI 10.1016/j.bbrc.2025.152770